WallStreetZenWallStreetZen

NASDAQ: CTCX
Carmell Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

CTCX past revenue growth

How has CTCX's revenue growth performed historically?
Company
82.88%
Industry
110.58%
Market
14.02%
CTCX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTCX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CTCX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CTCX earnings and revenue history

Current Revenue
$25.6M
Current Earnings
-$19.3M
Current Profit Margin
-75.1%

CTCX Return on Equity

Insufficient data to display

Be the first to know when CTCX announces earnings.

CTCX Return on Assets

Current Company
-72.1%
Current Industry
2.2%
CTCX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTCX Return on Capital Employed

Current Company
-36.72%
Current Industry
17.7%

CTCX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTCX$25.65M-$15.63M-$19.27M+82.88%N/A
APLM$0.00-$387.20M-$388.09MN/AN/A
ATHA$0.00-$119.35M-$120.52MN/AN/A
NKGN$77.00k-$78.39M-$83.67M-84.69%N/A
CGEN$7.50M-$32.95M-$33.46M-5.59%N/A
View Top Biotech Stocks

Carmell Earnings & Revenue FAQ

What were CTCX's earnings last quarter?

Carmell (NASDAQ: CTCX) reported Q3 2023 earnings per share (EPS) of -$0.62, up 90.8% year over year. Total Carmell earnings for the quarter were -$11.51 million. In the same quarter last year, Carmell's earnings per share (EPS) was -$6.74.

If you're new to stock investing, here's how to buy Carmell stock.

What was CTCX's earnings growth in the past year?

As of Q4 2023, Carmell's earnings has grown year over year. Carmell's earnings in the past year totalled -$19.27 million.

What was CTCX's revenue last quarter?

Carmell (NASDAQ: CTCX) reported Q3 2023 revenue of $3.73 million up Infinity% year over year. In the same quarter last year, Carmell's revenue was $0.00.

What was CTCX's revenue growth in the past year?

As of Q4 2023, Carmell's revenue has grown 82.88% year over year. This is 27.7 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Carmell's revenue in the past year totalled $25.65 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.